Ingevity Rises on Strategic Review, New Executive Appointments

Dow Jones
2025/12/10
 

By Elias Schisgall

 

Shares of Ingevity were higher after the chemicals company said it was exploring strategic alternatives for two of its business units, including a possible sale, and announced a set of leadership transitions.

Shares were up 7.2% at $57.84. The stock has risen 42% this year.

The company said Tuesday that it has completed a portfolio review and was looking at options for its Advanced Polymer Technologies segment and its Performance Chemicals Road Marking business, including a potential divestment.

"We have determined that our APT segment and Road Markings business are not fully aligned with Ingevity's core competencies nor its future strategic direction, which focuses on consistency, best-in-class margins and superior cash flow generation," Chief Executive Officer Dave Li said.

The company also said Phillip Platt would take over as chief financial officer effective May 1. Platt will succeed Mary Dean Hall, who started as CFO in 2021.

Rich White, currently president of the Performance Chemicals division, will move to a special projects role beginning in January before leaving the company in May, Ingevity said. And Reid Clontz, most recently vice president of global operations, was promoted to senior vice president for operations, effective immediately, the company said.

 

Write to Elias Schisgall at elias.schisgall@wsj.com

 

(END) Dow Jones Newswires

December 09, 2025 11:23 ET (16:23 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10